Overview
- India and the United States held their second India–US Drug Policy Executive Working Group in New Delhi on Nov 2–3 and agreed to institutionalize regular cooperation to fight transnational drug trafficking.
- The Indian delegation was led by NCB Director General Anurag Garg and the U.S. delegation by Acting Deputy Director Debbie Seguin of the ONDCP, who jointly reviewed bilateral work since the January meeting in Washington.
- Officials identified priority areas for action including faster intelligence sharing, coordinated law enforcement operations, stronger precursor chemical controls, protection of pharmaceutical supply chains, and demand-reduction programs.
- Both sides welcomed concrete steps already under way such as Operation MedMax, Operation WIPE, and India’s Voluntary Code of Conduct for precursors as tools to choke off chemicals used to make synthetic drugs.
- The meeting tied operational work to national strategies — India’s Vision Roadmap 2026–2029 and the U.S. 2026 National Drug Control Strategy — to align investigations, financial probes, and prevention efforts that aim to protect communities in both countries.